About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.
minkabu the infonoid
(C) 2024 MINKABU THE INFONOID, Inc.
kabutan

Medical Data Vision Co.,Ltd., The Current Fiscal Year Ordinary Profit Revised Downward by 75%

Mon Nov 11, 2024 3:30 pm JST Earnings

3902 Medical Data Vision Co.,Ltd. 【J-GAAP】

Earnings Report

Medical Data Vision Co.,Ltd. <3902> [TSE-P] announced its financial results after the market closed on November 11th (15:30). The consolidated ordinary profit/loss for the cumulative third quarter of the fiscal year ending December 2024 (January to September) turned into a loss of 229 million yen (compared to a profit of 1.06 billion yen in the same period last year).

In addition, the full-year consolidated ordinary profit has downwardly by 74.7%, from the previous forecast of 1.54 billion yen to 390 million yen (compared to 1.7 billion yen in the previous period), leading to an increase in the profit decline rate from 9.4% to 77.1%.

Based on the full-year plan announced by the company after the downward revision, our estimate of the consolidated ordinary profit for the July to December period (second half) has downwardly by 73.2%, from the previous forecast of 1.57 billion yen to 422 million yen (compared to 1 billion yen in the same period of the previous year). This changes the outlook from an anticipated profit increase to a projection of a 57.8% decrease in profit.

In the most recent three-month period, from July to September (3Q), the consolidated ordinary profit/loss turned to a loss of 197 million yen (compared to a profit of 363 million yen in the same period last year). The operating profit/loss margin drastically worsened from 26.4% in the same period last year to -12.3%.

Kabutan News

Actual Results

Accumulated Results 3rd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Jan - Sep, 2022 4,327 1,165 1,156 775 20.3 66.1 Nov 14, 2022 J-GAAP
Jan - Sep, 2023 4,487 1,111 1,063 659 17.3 62.5 Nov 13, 2023 J-GAAP
Jan - Sep, 2024 4,125 -140 -229 -314 -8.2 Nov 11, 2024 J-GAAP
YoY -8.1%

Guidance Update

Second Half Update

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jul - Dec, 2024 Prev 5,220 1,604 1,572 1,086 28.6 6.50 Aug 8, 2024 J-GAAP
Jul - Dec, 2024 New 3,820 484 422 266 7.0 6.50 Nov 11, 2024 J-GAAP
Revision Rate -26.8% -69.8% -73.2% -75.5% -75.5%

Full Year Update

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2024 Prev 8,000 1,630 1,540 1,000 26.4 6.50 Feb 13, 2024 J-GAAP
Dec, 2024 New 6,600 510 390 180 4.8 6.50 Nov 11, 2024 J-GAAP
Revision Rate -17.5% -68.7% -74.7% -82.0% -82.0%

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jul - Dec, 2023 3,417 1,051 1,000 534 14.0 6.50 Feb 13, 2024 J-GAAP
Jul - Dec, 2024 Guidance 3,820 484 422 266 7.0 6.50 Nov 11, 2024 J-GAAP
YoY +11.8% -53.9% -57.8% -50.2% -49.8%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2022 6,104 1,758 1,750 870 22.8 6 Feb 13, 2023 J-GAAP
Dec, 2023 6,419 1,770 1,700 979 25.6 6.50 Feb 13, 2024 J-GAAP
Dec, 2024 Guidance 6,600 510 390 180 4.8 6.50 Nov 11, 2024 J-GAAP
YoY +2.8% -71.2% -77.1% -81.6% -81.5%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Jul - Sep, 2023 1,485 392 363 214 5.6 26.4 Nov 13, 2023 J-GAAP
Oct - Dec, 2023 1,932 659 637 320 8.4 34.1 Feb 13, 2024 J-GAAP
Jan - Mar, 2024 1,388 53 22 -15 -0.4 3.8 May 13, 2024 J-GAAP
Apr - Jun, 2024 1,392 -27 -54 -71 -1.9 -1.9 Aug 8, 2024 J-GAAP
Jul - Sep, 2024 1,345 -166 -197 -228 -6.0 -12.3 Nov 11, 2024 J-GAAP
YoY -9.4%

Related Articles